Summary
Calcium hydroxyapatite [Ca₁₀(PO₄)₆(OH)₂] is widely used as a biocoating material for orthopedic and dental implants due to its excellent biocompatibility and osteoconductive properties. The coating promotes bone integration and provides long-term stability of titanium implants.
This application note demonstrates XRPD characterization of hydroxyapatite biocoatings for medical implants, with particular emphasis on phase purity control using NIST 2910 standard reference material.
Background & Importance
Hydroxyapatite in Medical Devices
Hydroxyapatite biocoatings are applied to metal implants (typically titanium alloys) to enhance bone integration. Common applications include:
- Hip replacements: Femoral stems with HA coating
- Knee implants: Tibial and femoral components
- Dental implants: Titanium screws with HA surface
- Spinal fusion devices: Cages and interbody devices
Quality Requirements
Critical parameter: Only the pure calcium hydroxyapatite phase should be present. Other phases such as α-TCP, β-TCP (tricalcium phosphate), or CaO (calcium oxide) are undesirable as they can affect biocompatibility and resorption characteristics.
XRPD is the definitive method for confirming phase purity and detecting unwanted crystalline phases in hydroxyapatite coatings.
Methods & Experimental Design
Sample Information
Reference material: NIST SRM 2910 (Calcium Hydroxyapatite)
XRPD Measurement
Instrument Parameters
- X-ray sourceCu Kα
- InstrumentLaboratory XRPD at DANNALAB
- Angular Range10-70 deg 2θ
- Reference standardNIST SRM 2910
Quality Control Approach
XRPD is used to control the purity of hydroxyapatite coatings against NIST 2910 standard reference material. The XRPD pattern is compared to the certified reference to confirm:
- Pure calcium hydroxyapatite phase (no secondary phases)
- Absence of α-TCP, β-TCP, or CaO impurities
- Proper crystallinity
Results
Figure 1. XRPD pattern of hydroxyapatite biocoating compared to NIST 2910 standard reference material, confirming phase purity.
XRPD analysis confirmed the coating contains only the calcium hydroxyapatite phase with no detectable secondary phases. Pattern matched NIST 2910 reference material, confirming phase purity suitable for medical device applications.
Key Finding: Only calcium hydroxyapatite [Ca₁₀(PO₄)₆(OH)₂] phase detected. No α-TCP, β-TCP, or CaO impurities present.
Conclusion
XRPD characterization against NIST 2910 standard reference material provides definitive confirmation of hydroxyapatite phase purity for medical implant coatings. This non-destructive analysis is essential for quality control and regulatory compliance of biocoated medical devices.